Comments
Loading...
Molecular Partners (MOLN) Forecast
NewsEarningsMolecular Partners (MOLN) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
Molecular Partners Stock Price, Quotes and Forecasts | NASDAQ:MOLN | Benzinga
Explore Molecular Partners stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for MOLN.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Molecular Partners (MOLN) stock?
You can purchase shares of Molecular Partners (NASDAQ:MOLN) through any online brokerage.
Who are Molecular Partners (MOLN) competitors?
Other companies in Molecular Partners’s space includes: Galectin Therapeutics (NASDAQ:GALT), DiaMedica Therapeutics (NASDAQ:DMAC), Elicio Therapeutics (NASDAQ:ELTX), Fate Therapeutics (NASDAQ:FATE) and Eupraxia Pharmaceuticals (NASDAQ:EPRX).
What is the forecast, or price target, for Molecular Partners (MOLN) stock?
Molecular Partners has a consensus price target of $8.17.
What is the current price for Molecular Partners (MOLN)?
The stock price for Molecular Partners (NASDAQ: MOLN) is $3.93 last updated June 23, 2025 at 6:22 AM EDT.
Does Molecular Partners (MOLN) pay a dividend?
There are no upcoming dividends for Molecular Partners.
When is Molecular Partners (NASDAQ:MOLN) reporting earnings?
Molecular Partners’s Q2 earnings are confirmed for Monday, August 25, 2025.
Is Molecular Partners (MOLN) going to split?
There is no upcoming split for Molecular Partners.
What sector and industry does Molecular Partners (MOLN) operate in?
Molecular Partners is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
